Abbott Labs (ABT)

Abbott Beats Expectations and Boosts '09 Forecast

Abbott Laboratories (ABT) reported a 36% increase in third-quarter profit, exceeding Wall Street expectations. The company also also boosted its financial forecast for 2009. The company's Q3 profit was boosted by higher sales of nutritional products and heart devices and accelerating sales growth for its top drug, arthritis treatment Humira.
Abbott's good news was another factor in the Dow Jones heading to 10,000.

Oct 14 · 11:36:00 AM · Source: Dow Jones News Wire
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter